Imiquimod 5-Percent Cream Does Not Alter the Natural History of Recurrent Herpes Genitalis: a Phase II, Randomized, Double-Blind, Placebo-Controlled Study

Present strategies for control of herpes genitalis recurrences require multiple daily doses of antiviral medication. Imiquimod, an immune response modifier, induces alpha interferon and interleukin-12; application in the presence of local herpes antigens during a recurrence may augment herpes simple...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Schacker, Timothy W., Conant, Marcus, Thoming, Christopher, Stanczak, Tamara, Wang, Zengri, Smith, Michael
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Clinical Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128805/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12234851/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.10.3243-3248.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!